PT Suparma Tbk (SPMA.JK)
IDR 300.0
(-0.66%)
IDR 300.0
(-0.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2658.52 Billion | 3138.05 Billion | 2794.45 Billion | 2151.49 Billion | 2514.16 Billion | 2389.26 Billion |
| Cost of Revenue | 2192.08 Billion | 2419.29 Billion | 2205.29 Billion | 1761.98 Billion | 2142.8 Billion | 2020.05 Billion |
| Gross Profit | 466.44 Billion | 718.75 Billion | 589.15 Billion | 389.51 Billion | 371.35 Billion | 369.21 Billion |
| Operating Expenses | 206.7 Billion | 192.45 Billion | 180.94 Billion | 156.97 Billion | 182.46 Billion | 160.73 Billion |
| Selling, General and Administrative Expenses | 211.37 Billion | 112.81 Billion | 105.55 Billion | 154.41 Billion | 176.58 Billion | 158.85 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 4.47 Billion | 5.35 Billion | -2.55 Billion | -5.88 Billion | -1.87 Billion |
| Cost and Expenses | 2403.45 Billion | 2611.74 Billion | 2386.23 Billion | 1918.95 Billion | 2325.27 Billion | 2180.79 Billion |
| Operating Income | 255.06 Billion | 464.48 Billion | 413.02 Billion | 232.53 Billion | 188.88 Billion | 208.47 Billion |
| Interest Expense | 37.9 Billion | 32.41 Billion | 31.11 Billion | 55.48 Billion | 60.42 Billion | 49.94 Billion |
| Income Tax Expense | 59.19 Billion | 95.3 Billion | 83.18 Billion | 32.97 Billion | 45.63 Billion | 27.44 Billion |
| Earnings before Tax | 237.84 Billion | 431.44 Billion | 377.5 Billion | 195.5 Billion | 176.64 Billion | 109.67 Billion |
| Net Income | 178.65 Billion | 336.13 Billion | 294.32 Billion | 162.52 Billion | 131 Billion | 82.23 Billion |
| Earnings Per Share Basic | 56.64 | 106.57 | 107.12 | 51.53 | 41.54 | 26.07 |
| Earnings Per Share Diluted | 56.64 | 106.57 | 107.12 | 51.53 | 41.54 | 26.07 |
| Weighted Average Shares Outstanding | 3.15 Billion | 3.15 Billion | 2.74 Billion | 3.15 Billion | 3.15 Billion | 3.15 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.15 Billion | 3.15 Billion | 2.74 Billion | 3.15 Billion | 3.15 Billion | 3.15 Billion |
| Gross Margin | 0.18 | 0.23 | 0.21 | 0.18 | 0.15 | 0.15 |
| EBIT Margin | 0.13 | 0.15 | 0.15 | 0.15 | 0.11 | 0.12 |
| Profit Margin | 0.07 | 0.11 | 0.11 | 0.08 | 0.05 | 0.03 |
| EBITDA | 352.01 Billion | 467.59 Billion | 416.31 Billion | 322.46 Billion | 314.34 Billion | 251.55 Billion |
| Earnings Before Tax Margin | 0.10 | 0.15 | 0.15 | 0.11 | 0.08 | 0.09 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 686.13 Billion | 618.18 Billion | 657.61 Billion | 2658.52 Billion | 706.23 Billion | 650.52 Billion |
| Cost of Revenue | 595.69 Billion | 511.5 Billion | 541.2 Billion | 2192.08 Billion | 592.8 Billion | 538.68 Billion |
| Gross Profit | 90.44 Billion | 106.68 Billion | 116.4 Billion | 466.44 Billion | 113.42 Billion | 111.83 Billion |
| Operating Expenses | 50.48 Billion | 48.1 Billion | 59.34 Billion | 211.37 Billion | 53.99 Billion | 52.49 Billion |
| Selling, General and Administrative Expenses | 50.48 Billion | 48.1 Billion | 59.34 Billion | - | 53.99 Billion | 31.48 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 526.74 Million | 63.17 Million | 6.06 Billion | 927.02 Million | 1.46 Billion |
| Cost and Expenses | 646.17 Billion | 559.61 Billion | 600.55 Billion | 2403.45 Billion | 646.79 Billion | 591.18 Billion |
| Operating Income | 39.96 Billion | 58.57 Billion | 57.05 Billion | 255.06 Billion | 59.43 Billion | 36.24 Billion |
| Interest Expense | 7.19 Billion | 10.3 Billion | 9.88 Billion | 34.63 Billion | 10.17 Billion | 8.01 Billion |
| Income Tax Expense | 18.37 Billion | 5.25 Billion | 7.72 Billion | 59.19 Billion | 19.03 Billion | 6.39 Billion |
| Earnings before Tax | 84.23 Billion | 31.67 Billion | 30.31 Billion | 237.84 Billion | 53.96 Billion | 30.72 Billion |
| Net Income | 65.86 Billion | 26.41 Billion | 22.58 Billion | 178.65 Billion | 34.92 Billion | 24.33 Billion |
| Earnings Per Share Basic | 20.88 | 8.38 | 7.16 | - | 11.07 | 7.72 |
| Earnings Per Share Diluted | 20.88 | 8.38 | 7.16 | - | 11.07 | 7.72 |
| Weighted Average Shares Outstanding | 3.15 Billion | 3.15 Billion | 3.15 Billion | 3.15 Billion | 3.15 Billion | 3.15 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.15 Billion | 3.15 Billion | 3.15 Billion | 3.15 Billion | 3.15 Billion | 3.15 Billion |
| Gross Margin | 0.13 | 0.17 | 0.18 | 0.18 | 0.16 | 0.17 |
| EBIT Margin | 0.17 | 0.14 | 0.13 | - | 0.12 | 0.06 |
| Profit Margin | 0.10 | 0.04 | 0.03 | 0.07 | 0.05 | 0.04 |
| EBITDA | 119.99 Billion | 86.9 Billion | 85.11 Billion | - | 87.15 Billion | 37.33 Billion |
| Earnings Before Tax Margin | 0.06 | 0.09 | 0.09 | 0.10 | 0.08 | 0.06 |
CSNVY
271560
091700
CDRO
SSIA
020000